ANTIHYPERTENSIVE AND METABOLIC EFFECTS OF A NEW CONVERTING ENZYME-INHIBITOR, ENALAPRIL

被引：49

作者：

CHRYSANT, SG

BROWN, RD

KEM, DC

BROWN, JL

机构：

[1] UNIV KANSAS,MED CTR,KANSAS CITY,KS 66103

[2] UNIV OKLAHOMA,HLTH SCI CTR,OKLAHOMA CITY,OK 73190

来源：

CLINICAL PHARMACOLOGY & THERAPEUTICS | 1983年 / 33卷 / 06期

关键词：

D O I：

10.1038/clpt.1983.101

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：741 / 746

页数：6

共 31 条

[1] 3 NEW LONG-ACTING CONVERTING-ENZYME INHIBITORS - RELATIONSHIP BETWEEN PLASMA CONVERTING-ENZYME ACTIVITY AND RESPONSE TO ANGIOTENSIN-I [J].

BIOLLAZ, J ;

BURNIER, M ;

TURINI, GA ;

BRUNNER, DB ;

PORCHET, M ;

GOMEZ, HJ ;

JONES, KH ;

FERBER, F ;

ABRAMS, WB ;

GAVRAS, H ;

BRUNNER, HR .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (05) :665-670

[2] ORAL ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTS [J].

BRUNNER, HR ;

GAVRAS, H ;

WAEBER, B ;

KERSHAW, GR ;

TURINI, GA ;

VUKOVICH, RA ;

MCKINSTRY, DN ;

GAVRAS, I .

ANNALS OF INTERNAL MEDICINE, 1979, 90 (01) :19-23

[3] CLINICAL EXPERIENCE WITH BLOCKADE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BY AN ORAL CONVERTING-ENZYME INHIBITOR (SQ 14,225, CAPTOPRIL) IN HYPERTENSIVE PATIENTS [J].

CASE, DB ;

ATLAS, SA ;

LARAGH, JH ;

SEALEY, JE ;

SULLIVAN, PA ;

MCKINSTRY, DN .

PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 21 (03) :195-206

[4] PROTEINURIA DURING LONG-TERM CAPTOPRIL THERAPY [J].

CASE, DB ;

ATLAS, SA ;

MOURADIAN, JA ;

FISHMAN, RA ;

SHERMAN, RL ;

LARAGH, JH .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1980, 244 (04) :346-349

[5] RACIAL-DIFFERENCES IN PRESSURE, VOLUME AND RENIN INTERRELATIONSHIPS IN ESSENTIAL HYPERTENSION [J].

CHRYSANT, SG ;

DANISA, K ;

KEM, DC ;

DILLARD, BL ;

SMITH, WJ ;

FROHLICH, ED .

HYPERTENSION, 1979, 1 (02) :136-141

[6]

CHRYSANT SG, 1980, CIRCULATION, V62, P188

[7]

CHRYSANT SG, ARCH INTERN MED

[8] REVERSIBLE RENAL-FAILURE DURING TREATMENT WITH CAPTOPRIL [J].

COLLSTE, P ;

HAGLUND, K ;

LUNDGREN, G ;

MAGNUSSON, G ;

OSTMAN, J .

BRITISH MEDICAL JOURNAL, 1979, 2 (6190) :612-613

[9]

CRESSMAN MD, 1982, LANCET, V2, P440

[10] MK-421 - A NEW ORAL ANGIOTENSIN CONVERTING ENZYME-INHIBITOR FOR ESSENTIAL-HYPERTENSION [J].

FERGUSON, RK ;

VLASSES, PH ;

SWANSON, BN ;

COOPER, DJ ;

DAVIES, RO ;

ABRAMS, WB .

AMERICAN JOURNAL OF CARDIOLOGY, 1981, 47 (02) :470-470

← 1 2 3 4 →